Arthroscopy Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Arthroscopy Devices Market Trends and Insights

Rising Burden of Musculoskeletal Disorders

Global osteoarthritis cases reached 606.5 million in 2021, with prevalence accelerating among women and the elderly. Musculoskeletal disease now ranks as the second-largest cause of years lived with disability, pushing payors toward cost-effective arthroscopic solutions. Projections suggest that nearly 50% of post-menopausal women could have osteoarthritis by 2045. Demand growth therefore aligns directly with demographic aging and rising life expectancy in both developed and emerging regions.

Shift Toward Minimally Invasive Orthopedic Procedures

Average hospital stay falls by 2-3 days when arthroscopy replaces open surgery, translating to measurable payor savings and improved patient satisfaction^{[1]UC Davis Health Press Office, “Arthroscopy Shortens Hospital Stay,” health.ucdavis.edu}. Uptake is further propelled by 4K visualization, wireless cameras, and robotic assistance that expand indications once considered too complex for a portal approach. Younger patients favor the faster rehabilitation and smaller scars relative to open repair.

Continuous Technological Innovation in Arthroscopic Equipment

Augmented-reality guidance platforms such as the TESSA Spatial Surgery System deliver real-time alignment cues for ligament reconstruction, reducing technical error risk. Wireless camera suites eliminate cables and shorten setup time while preserving HD image quality. Nano-arthroscopy scopes as small as 2 mm enable office-based diagnostic procedures that lower facility costs and broaden access. AI-driven planning tools refine tunnel placement and predict graft tension, enhancing outcomes.

Growing Participation in Sports and Physical Fitness Activities

Between 2014-2023, soccer generated 843,063 lower-extremity injuries in the United States alone, with ankle trauma comprising 36.39% of cases and 63.24% occurring in the 10-19 age cohort^{[2]Paolo Maduri, “Lower-Extremity Soccer Injuries 2014-2023,” Orthopedic Reviews, pagepressjournals.org}. Basketball and field sports show similarly high joint-injury incidence, especially ACL tears among female athletes that often require reconstruction. Year-round specialization elevates overuse lesions, ensuring a steady procedure pipeline for shoulder, knee, and ankle scopes.

High Capital and Procedural Costs

A fully equipped arthroscopy suite requires upfront investment above USD 500,000, while consumables add USD 2,000-5,000 per case, pressuring facilities with modest volumes^{[3]Elise Bland, “Cost Analysis of Arthroscopic Operating Suites,” BMC Health Services Research, bmc.org}. Inventory demands escalate when covering multiple joints, and reimbursement often fails to offset the premium of single-use disposables.

Stringent Regulatory and Reimbursement Hurdles

The 2022 Medical Device User Fee Amendments introduced higher review fees and more extensive post-market obligations, stretching time to market and development budgets. Prior-authorization rules for certain pain-management codes illustrate the administrative complexity that can dampen procedure numbers. Europe’s MDR likewise tightens clinical evidence requirements, forcing smaller innovators to seek partnerships with established firms.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Application: Knee Procedures Drive Volume While Hip Arthroscopy Accelerates

Knee procedures accounted for 44.78% of 2025 revenues, underscoring the joint’s high injury incidence and the maturity of arthroscopic ACL and meniscus repair protocols. Stable reimbursement and extensive surgeon familiarity cement volume leadership. Hip arthroscopy, although smaller today, is growing at a 7.45% CAGR on wider recognition of femoroacetabular impingement and labral tears in younger athletes. Access-refining cannulas and flexible burrs mitigate the steep learning curve, opening the segment to more community hospitals. Shoulder and elbow scopes benefit from bio-inductive patch implants that cut re-tear rates, while endoscopic spine portals inch into mainstream as companies extend platforms to disc decompression. Collectively, procedure mix is tilting from diagnostic lavage to reconstructive repair, a shift that lifts average selling price across the arthroscopy devices market.

The arthroscopy devices market size for knee interventions is projected to advance steadily through 2031, supported by sports-related ligament repair and degenerative meniscus management. In contrast, hip procedures hold only a mid-teens share today but are forecast to command a materially larger slice of the arthroscopy devices market share as implants, pumps, and visualization systems adapt to deep-joint ergonomics. Varied joint adoption rates keep manufacturers investing in joint-specific shaver burrs, suture passers, and fixation anchors, reinforcing segmentation in their catalogs and service models.

By Product: Implants Lead Value While Motorized Systems Drive Innovation

Implants generated 32.12% of 2025 sales, reflecting premium pricing for bioabsorbable screws, knotless anchors, and collagen scaffolds that convert simple debridement cases into tissue-preserving reconstructions. Material science breakthroughs such as magnesium-alloy screws and PLLA-TCP composites improve integration and fade radiographically over time, appealing to younger demographics. Motorized shavers and resection systems, posting an 7.86% CAGR, capture surgeon demand for precision cutting and efficient cartilage contouring. Variable-speed consoles, smart-blade recognition, and integrated suction elevate OR throughput and safety.

Visualization towers remain the centerpiece of capital deals. Wireless camera heads reduce clutter, while 4K and impending 8K sensors sharpen anatomic detail, especially during micro-work inside the hip. Fluid-management pumps now feature closed-loop pressure control that prevents extravasation. RF ablation probes and plasma wands carve a niche in soft-tissue sculpting, whereas handheld instruments sustain a baseline of demand for basic grasping and probing tasks. End-to-end portfolio bundling allows leading firms to lock in long-term service contracts and upsell consumable packs, reinforcing their hold on the arthroscopy devices market.

By End User: Hospitals Dominate While ASCs Accelerate Adoption

Hospital operating rooms represented 68.02% of global revenue in 2025 owing to their capacity to manage multi-joint, multi-ligament cases and provide intensive perioperative care. Large IDNs negotiate bulk contracts that bundle implants, towers, and training, driving scale for top suppliers. The ambulatory segment, however, is growing faster at an 8.12% CAGR as payors push routine knee and shoulder scopes to lower-cost venues. CMS rate parity between ASCs and hospital outpatient departments heightens this shift, and equipment makers now release compact towers tailored to the space constraints of ASCs.

Orthopedic and sports-medicine clinics increasingly incorporate diagnostic nano-arthroscopy to deliver same-day answers and triage patients for surgery, adding a valuable referral stream. Digital monitoring platforms let these clinics track post-operative progress remotely, improving outcomes and patient loyalty. Segment dynamics reveal that procedure acuity rather than sheer volume determines facility choice, with high-complexity hip reconstructions still gravitating to tertiary hospitals, while single-ligament knee repairs migrate to outpatient settings.

Geography Analysis

North America generated 42.05% of 2025 sales, underpinned by high training capacity, strong insurer coverage, and a population that remains physically active into older age. The United States drives most demand; Medicare’s 3.8% outpatient rate update sustains hospital margins while validating ASC migration. Canada’s single-payer model steadies annual procedure counts, and Mexico’s growing medical tourism market draws patients seeking lower-priced arthroscopic repair.

Europe ranks second in revenue, balancing strict regulation with a large base of skilled surgeons. The EU’s push for greener devices encourages early adoption of reusable shaver handpieces and recyclable tubing. Aging demographics feed hip and shoulder volumes, and national sports programs keep knee scopes common among younger cohorts. Clinical-outcome evidence requirements foster tight links between suppliers and academic centers that run prospective registries, strengthening the data core of the arthroscopy devices market.

Asia-Pacific is the fastest-growing region at a 6.39% CAGR. China’s centralized procurement lowers implant pricing, allowing wider hospital penetration. Domestic OEMs emerge, but international brands retain a technology edge in 4K visualization and navigation. Japan’s robotics leadership supports the rollout of AI-guided portals, and its super-aging society guarantees steady case growth. India’s public-private partnerships fund new arthroscopy labs, and government Make-in-India policies spur local assembly to lower import duties. Southeast Asian countries expand private insurance coverage, unlocking elective knee arthroscopy demand among a burgeoning middle class. Collectively, rising disposable income and improved hospital capacity translate into sustained volume gains across the arthroscopy devices market.

Regulatory Landscape

In the United States, key arthroscopy device categories such as arthroscopes are regulated by the FDA under 21 CFR Part 888 as Class II devices (commonly via the 510(k) premarket notification pathway), while some arthroscopic accessories are regulated as Class I devices with broader exemption from 510(k) requirements, depending on design and intended use. This structure keeps market entry feasible for incremental innovations (for example, specialized arthroscopes and component instruments) while still requiring manufacturers to demonstrate substantial equivalence and maintain post-market controls where applicable.

A major near-term compliance anchor is the FDA Quality Management System Regulation (QMSR), which takes effect on February 2, 2026 and incorporates ISO 13485:2016 into the US quality framework. In Europe, devices are governed by the EU Medical Device Regulation (EU) 2017/745 (MDR), where Annex VIII risk classification and Notified Body involvement (beyond Class I) drive higher documentation and clinical-evidence expectations. As a result, firms have placed more emphasis on established regulatory infrastructure and consistent QMS adoption across multinational arthroscopy portfolios.

Market Opportunities and Future Outlook

Platform-led opportunities are expanding as major orthopedics players operationalize AI-assisted navigation and tracking technologies that connect implants, visualization, and enabling tech into a single workflow. In June 2026, DePuy Synthes announced US commercial availability of VELYS Hip Navigation with AI Assistance, highlighting momentum for intraoperative automation that can be bundled with procedure-specific implants and service contracts. The same direction shows up in enabling technologies: in May 2026, DePuy Synthes also announced an agreement to acquire Gemtrack miniature radiofrequency tracking technology (MinMaxMedical), supporting navigation approaches that reduce line-of-sight constraints and broaden use across varying OR setups.

There is also visible whitespace in procedure settings and product form factors where compact, workflow-efficient systems and newer fixation constructs can fit outpatient care pathways. Smith+Nephew reported first clinical cases with its next-generation CORI XT handheld robotics platform (June 2026), backing demand for smaller-footprint, procedure-enabling equipment that aligns with ASCs and high-throughput hospital units. On the implant side, Arthrex released the TightRope SB all-suture implant for ACL fixation (February 2026), reflecting continued conversion from metal and rigid fixation toward soft-tissue friendly constructs that can be packaged with arthroscopic instrumentation, shavers, and visualization systems for joint-specific procedural kits.